In line with this hypothesis, van Dijk et al. (31) showed that serum IGF1 levels are higher in patients with type 1 diabetes treated with insulin through the intraperitoneal route versus the s.c. route. This evidence concerns the gene IGF1 and type 1 diabetes mellitus.